Nifty
:
24302.15
Sensex
:
80049.67
15.65 (0.06%)
62.87 (0.08%)
Nifty
Sensex
:
:
24302.15
80049.67
15.65 (0.06%)
62.87 (0.08%)

Zim Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
39/99

BSE: 541400 | NSE: ZIMLAB

NSE BSE
111.81
04-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  115.83
  •  117.39
  •  110.21
  •  115.01
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  455482
  •  519.62
  •  152.70
  •  89.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 559.86
  • 32.46
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 655.61
  • N/A
  • 2.35

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.26%
  • 6.70%
  • 49.01%
  • FII
  • DII
  • Others
  • 0.01%
  • 0.00%
  • 11.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.27
  • 5.76
  • 3.29

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.81
  • 12.82
  • 0.17

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 39.21
  • 5.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 25.49
  • 28.83

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 1.61
  • 2.07

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.43
  • 9.92

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
117.86
105.41
11.81%
96.29
100.97
-4.64%
85.83
99.40
-13.65%
67.44
92.75
-27.29%
Expenses
102.22
89.96
13.63%
84.76
87.88
-3.55%
76.50
87.14
-12.21%
62.61
81.56
-23.23%
EBITDA
15.65
15.45
1.29%
11.53
13.09
-11.92%
9.32
12.26
-23.98%
4.83
11.18
-56.80%
EBIDTM
13.28%
14.66%
11.98%
12.97%
10.86%
12.34%
7.16%
12.06%
Other Income
1.53
0.69
121.74%
1.11
2.40
-53.75%
1.42
1.42
0.00%
1.12
1.90
-41.05%
Interest
2.28
1.27
79.53%
1.70
1.62
4.94%
1.22
1.36
-10.29%
1.73
1.33
30.08%
Depreciation
3.90
4.93
-20.89%
3.94
3.90
1.03%
4.09
4.37
-6.41%
4.03
4.27
-5.62%
PBT
11.00
9.95
10.55%
7.02
9.98
-29.66%
5.44
7.95
-31.57%
0.19
7.48
-97.46%
Tax
2.91
2.71
7.38%
2.23
3.38
-34.02%
1.29
2.50
-48.40%
-0.04
2.33
-
PAT
8.09
7.24
11.74%
4.79
6.60
-27.42%
4.15
5.45
-23.85%
0.23
5.15
-95.53%
PATM
6.86%
6.87%
4.97%
6.54%
4.83%
5.48%
0.34%
5.55%
EPS
1.66
1.49
11.41%
0.98
1.35
-27.41%
0.85
1.12
-24.11%
0.05
1.06
-95.28%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
-
367.42
398.53
333.43
307.26
277.74
335.37
272.80
235.01
268.51
266.33
Net Sales Growth
-
-7.81%
19.52%
8.52%
10.63%
-17.18%
22.94%
16.08%
-12.48%
0.82%
 
Cost Of Goods Sold
-
171.44
198.83
160.35
158.63
143.14
159.51
140.89
119.96
157.72
181.51
Gross Profit
-
195.98
199.69
173.08
148.63
134.60
175.86
131.91
115.04
110.79
84.82
GP Margin
-
53.34%
50.11%
51.91%
48.37%
48.46%
52.44%
48.35%
48.95%
41.26%
31.85%
Total Expenditure
-
326.09
346.54
292.45
267.50
255.13
293.34
238.02
203.53
239.32
244.95
Power & Fuel Cost
-
13.47
11.09
9.14
7.04
7.47
7.19
5.75
5.35
6.40
6.33
% Of Sales
-
3.67%
2.78%
2.74%
2.29%
2.69%
2.14%
2.11%
2.28%
2.38%
2.38%
Employee Cost
-
53.34
49.32
40.07
35.76
35.35
48.26
40.80
33.00
30.70
23.26
% Of Sales
-
14.52%
12.38%
12.02%
11.64%
12.73%
14.39%
14.96%
14.04%
11.43%
8.73%
Manufacturing Exp.
-
39.34
33.83
29.03
23.40
26.97
13.62
7.82
7.76
7.25
7.18
% Of Sales
-
10.71%
8.49%
8.71%
7.62%
9.71%
4.06%
2.87%
3.30%
2.70%
2.70%
General & Admin Exp.
-
17.98
19.55
15.82
10.72
11.61
14.53
10.85
10.30
8.61
6.21
% Of Sales
-
4.89%
4.91%
4.74%
3.49%
4.18%
4.33%
3.98%
4.38%
3.21%
2.33%
Selling & Distn. Exp.
-
24.48
27.94
32.70
27.96
24.51
45.61
28.22
22.53
22.04
16.70
% Of Sales
-
6.66%
7.01%
9.81%
9.10%
8.82%
13.60%
10.34%
9.59%
8.21%
6.27%
Miscellaneous Exp.
-
6.04
5.98
5.35
3.98
6.07
4.62
3.69
4.62
6.60
16.70
% Of Sales
-
1.64%
1.50%
1.60%
1.30%
2.19%
1.38%
1.35%
1.97%
2.46%
1.41%
EBITDA
-
41.33
51.99
40.98
39.76
22.61
42.03
34.78
31.48
29.19
21.38
EBITDA Margin
-
11.25%
13.05%
12.29%
12.94%
8.14%
12.53%
12.75%
13.40%
10.87%
8.03%
Other Income
-
5.18
6.41
4.40
2.34
4.52
2.05
3.42
5.51
3.91
2.48
Interest
-
6.92
5.58
8.31
10.90
12.65
10.59
9.34
10.47
13.65
10.32
Depreciation
-
15.95
17.47
16.03
15.79
14.41
11.42
9.79
9.02
8.76
7.13
PBT
-
23.64
35.35
21.04
15.41
0.07
22.07
19.07
17.50
10.69
6.41
Tax
-
6.40
10.92
6.49
2.91
-3.23
6.73
5.83
-1.09
0.26
-5.00
Tax Rate
-
27.07%
30.89%
30.85%
28.45%
-4614.29%
30.49%
23.39%
-6.23%
4.85%
18.79%
PAT
-
17.25
24.43
14.55
7.32
3.30
15.34
19.11
18.59
5.10
-21.61
PAT before Minority Interest
-
17.25
24.43
14.55
7.32
3.30
15.34
19.11
18.59
5.10
-21.61
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
4.69%
6.13%
4.36%
2.38%
1.19%
4.57%
7.01%
7.91%
1.90%
-8.11%
PAT Growth
-
-29.39%
67.90%
98.77%
121.82%
-78.49%
-19.73%
2.80%
264.51%
-
 
EPS
-
3.54
5.02
2.99
1.50
0.68
3.15
3.92
3.82
1.05
-4.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
238.75
200.35
175.71
160.75
153.82
151.12
136.60
118.33
98.96
94.21
Share Capital
48.73
48.73
16.24
16.24
16.18
16.12
8.06
8.03
8.00
8.00
Total Reserves
190.02
151.62
159.47
144.51
137.28
133.77
127.95
109.59
90.34
86.21
Non-Current Liabilities
48.65
30.45
20.01
19.40
22.72
20.19
16.61
18.09
34.75
37.59
Secured Loans
35.60
24.62
18.92
21.83
27.01
19.14
15.91
26.75
33.98
36.77
Unsecured Loans
0.00
0.00
0.00
0.00
0.41
3.02
4.37
0.77
0.77
0.82
Long Term Provisions
0.00
0.00
0.00
0.01
0.00
0.10
0.00
0.00
0.00
0.00
Current Liabilities
159.43
110.79
147.37
142.04
143.44
156.40
141.40
113.21
123.65
134.38
Trade Payables
62.38
58.24
81.07
64.87
66.00
71.95
66.26
45.05
46.97
64.12
Other Current Liabilities
41.21
29.07
44.71
31.16
26.68
38.65
25.15
18.33
16.71
17.24
Short Term Borrowings
55.04
22.88
17.34
44.60
49.69
40.15
49.56
46.70
56.30
51.42
Short Term Provisions
0.80
0.59
4.24
1.40
1.06
5.65
0.43
3.14
3.68
1.61
Total Liabilities
446.83
341.59
343.09
322.19
319.98
327.71
294.61
249.63
257.36
266.18
Net Block
160.83
108.66
105.64
106.52
115.92
106.01
94.16
88.75
92.19
87.11
Gross Block
266.57
198.66
180.24
165.49
159.23
135.67
112.90
97.77
120.36
107.50
Accumulated Depreciation
105.74
90.01
74.60
58.97
43.31
29.66
18.74
9.02
28.17
20.39
Non Current Assets
219.17
150.63
129.49
130.43
137.94
132.39
121.68
95.86
102.02
96.71
Capital Work in Progress
42.28
26.99
11.74
10.68
9.62
13.32
8.29
3.82
2.93
5.62
Non Current Investment
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Long Term Loans & Adv.
15.71
14.41
11.78
11.32
10.40
11.72
17.33
2.35
6.36
3.65
Other Non Current Assets
0.31
0.52
0.28
1.85
1.95
1.29
1.84
0.87
0.48
0.28
Current Assets
227.65
190.95
213.59
191.76
182.03
195.32
172.94
153.77
155.34
169.46
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
81.26
53.71
75.28
54.35
56.39
55.05
51.56
35.47
37.72
46.10
Sundry Debtors
100.17
95.25
89.52
72.25
67.93
93.10
89.22
88.18
88.53
81.29
Cash & Bank
10.46
7.52
4.97
8.35
3.95
2.94
3.53
5.61
6.39
7.69
Other Current Assets
35.75
2.56
1.41
1.55
53.76
44.23
28.63
24.52
22.70
34.39
Short Term Loans & Adv.
33.46
31.91
42.41
55.26
52.16
42.83
27.51
23.51
21.49
33.92
Net Current Assets
68.22
80.16
66.23
49.72
38.60
38.92
31.54
40.56
31.69
35.09
Total Assets
446.82
341.58
343.08
322.19
319.97
327.71
294.62
249.63
257.36
266.17

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
16.28
38.17
49.21
31.85
21.92
34.94
36.68
32.07
21.94
PBT
23.64
35.35
21.04
15.41
0.07
22.07
24.94
17.50
5.36
Adjustment
22.01
22.16
22.01
25.79
26.25
23.82
12.84
20.78
29.04
Changes in Working Capital
-26.79
-12.19
6.58
-8.24
0.56
-9.64
2.96
-3.72
-11.32
Cash after chg. in Working capital
18.86
45.32
49.64
32.96
26.87
36.25
40.73
34.56
23.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-2.58
-7.15
-0.43
-1.11
-4.96
-1.31
-4.06
-2.49
-1.14
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-73.01
-36.20
-14.57
-5.88
-19.41
-20.68
-25.83
-7.24
-11.73
Net Fixed Assets
-81.96
-32.76
-15.55
-7.23
-19.28
-22.29
-19.60
21.70
Net Investments
-0.05
0.00
-0.10
0.00
-3.54
-4.45
0.00
0.00
Others
9.00
-3.44
1.08
1.35
3.41
6.06
-6.23
-28.94
Cash from Financing Activity
59.53
0.55
-32.97
-25.97
-2.16
-15.16
-9.80
-25.15
-10.35
Net Cash Inflow / Outflow
2.80
2.51
1.66
0.00
0.35
-0.90
1.04
-0.32
-0.14
Opening Cash & Equivalents
6.42
3.42
1.39
1.46
0.50
1.47
0.42
0.74
0.88
Closing Cash & Equivalent
9.60
6.42
3.42
1.39
1.46
0.50
1.47
0.42
0.74

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
49.00
41.12
36.06
32.99
94.84
92.99
84.38
73.25
61.47
58.89
ROA
4.38%
7.14%
4.37%
2.28%
1.02%
4.93%
7.02%
7.33%
1.95%
-8.12%
ROE
7.86%
13.00%
8.65%
4.66%
2.17%
10.73%
15.07%
17.21%
5.29%
-22.94%
ROCE
10.11%
16.82%
12.52%
8.70%
5.39%
14.64%
16.46%
14.20%
9.95%
-8.70%
Fixed Asset Turnover
1.58
2.10
1.93
1.89
1.88
2.70
2.60
2.21
2.43
2.56
Receivable days
97.06
84.61
88.55
83.26
105.81
99.21
118.05
133.84
112.03
107.85
Inventory Days
67.04
59.07
70.95
65.77
73.23
58.02
57.91
55.43
55.29
61.16
Payable days
128.40
127.86
166.10
150.56
175.89
88.19
86.92
85.73
87.08
96.17
Cash Conversion Cycle
35.70
15.82
-6.61
-1.53
3.15
69.04
89.04
103.54
80.25
72.85
Total Debt/Equity
0.44
0.30
0.29
0.50
0.59
0.52
0.60
0.68
0.98
0.99
Interest Cover
4.41
7.34
3.53
1.94
1.01
3.08
3.67
2.67
1.39
-1.58

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • ZIM Laboratories invests Rs 68.25 lakh in ZIMTAS
    2nd Jul 2024, 15:42 PM

    Post investment, the company holds 99.93% of the total share capital of ZIMTAS

    Read More
  • ZIM Laboratories gets nod to invest Rs 40 lakh in SIA ZIM Laboratories
    14th May 2024, 09:59 AM

    With the proposed investment, the company’s shareholding in SIA ZIM Laboratories Limited remains at 100%

    Read More
  • ZIM Laboratories gets nod to invest Rs 2 crore in ZIMTAS
    14th May 2024, 09:39 AM

    The Board of Directors of the company in their meeting held on May 13, 2024 has inter-alia considered and approved the same

    Read More
  • Zim Laboratories - Quarterly Results
    13th May 2024, 21:29 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.